# Effect of Ferric Carboxymaltose on Exercise Capacity After Kidney Transplantation

> **NCT03769441** · PHASE3 · COMPLETED · sponsor: **University Medical Center Groningen** · enrollment: 148 (actual)

## Conditions studied

- Iron-deficiency
- Transplant-Related Disorder

## Interventions

- **DRUG:** Ferric carboxymaltose
- **DRUG:** Sodium chloride

## Key facts

- **NCT ID:** NCT03769441
- **Lead sponsor:** University Medical Center Groningen
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-08-02
- **Primary completion:** 2024-08-19
- **Final completion:** 2024-08-19
- **Target enrollment:** 148 (ACTUAL)
- **Last updated:** 2024-08-27

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03769441

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03769441, "Effect of Ferric Carboxymaltose on Exercise Capacity After Kidney Transplantation". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03769441. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*